首页> 外文OA文献 >The protease-activated receptor 4 Ala120Thr variant alters platelet responsiveness to low-dose thrombin and protease-activated receptor 4 desensitization, and is blocked by non-competitive P2Y12 inhibition

【2h】

The protease-activated receptor 4 Ala120Thr variant alters platelet responsiveness to low-dose thrombin and protease-activated receptor 4 desensitization, and is blocked by non-competitive P2Y12 inhibition

机译：蛋白酶活化受体4AlA120Th变化改变血小板反应性与低剂量凝血酶和蛋白酶活化受体4脱敏，并通过非竞争性P2Y12抑制阻止

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
M. J. Whitley; D. M. Henke; A. Ghazi; M. Nieman; M. Stoller; L. M. Simon; E. Chen; J. Vesci; M. Holinstat; S. E. McKenzie; C. A. Shaw; L. C. Edelstein; P. F. Bray;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The protease‐activated receptor?4 Ala120Thr variant alters platelet responsiveness to low‐dose thrombin and protease‐activated receptor?4 desensitization, and is blocked by non‐competitive P2Y 12 12 inhibition [J] . Whitley M. J., Henke D. M., Ghazi A., Journal of thrombosis and haemostasis: JTH . 2018,第12期

机译：蛋白酶活化受体α4Ala120th变体改变血小板反应与低剂量凝血酶和蛋白酶活化受体Δ4脱敏，并通过非竞争性P2Y 12 12抑制阻止
2. Human platelet protease-activated receptor-1 responsiveness to thrombin related to P2Y12 inhibition [J] . BadrEslamR., LangI.M., KaiderA., Translational research: the journal of laboratory and clinical medicine . 2013,第5期

机译：人血小板蛋白酶激活受体-1对凝血酶的应答与P2Y12抑制有关
3. Defective platelet responsiveness to thrombin and protease-activated receptors agonists in a novel case of gray platelet syndrome: correlation between the platelet defect and the alpha-granule content in the patient and four relatives. [J] . DE-Candia E, Pecci A, Ciabattoni G, Journal of thrombosis and haemostasis: JTH . 2007,第3期

机译：在新的灰色血小板综合症病例中，血小板对凝血酶和蛋白酶激活受体激动剂的血小板反应性不足：患者和四个亲属的血小板缺陷与α-颗粒含量之间的相关性。
4. Effects of telmisartan on arterial vasodilation via protease-activated receptor-2 activation in SHRSP.Z-Leprfa/IzmDmcr rats with metabolic syndrome [C] . Kagota S., Maruyama K., Wakuda H., International Congress on Coronary Artery Disease. . 2013

机译：综外原对SHRSP.Z-Leprfa / IzmdMCR大鼠蛋白酶活化受体-2激活动脉血管血管血管血管血管血管血管血管血管综合征的影响
5. Protease-activated receptor-2 (PAR2) in epithelial biology. [D] . Barker, Adrian. 2013

机译：上皮生物学中的蛋白酶激活受体2（PAR2）。
6. Conserved structure and adjacent location of the thrombin receptor and protease-activated receptor 2 genes define a protease-activated receptor gene cluster. [O] . M. Kahn, K. Ishii, W. L. Kuo, 1996

机译：凝血酶受体和蛋白酶激活受体2基因的保守结构和邻近位置定义了蛋白酶激活受体基因簇。
7. Defective platelet responsiveness to thrombin and protease-activated receptors agonists in a novel case of gray platelet syndrome: correlation between the platelet defect and theα-granule content in the patient and four relatives [O] . E. DE CANDIA, A. PECCI, G. CIABATTONI, 2007

机译：血小板和蛋白酶活化的受体激素缺陷血小板和蛋白酶活化的受体中的灰色血小板综合征的激动剂：患者血小板缺陷与α-颗粒含量与四个亲属之间的相关性

The protease-activated receptor 4 Ala120Thr variant alters platelet responsiveness to low-dose thrombin and protease-activated receptor 4 desensitization, and is blocked by non-competitive P2Y12 inhibition

著录项

引文网络

相似文献

相关主题

期刊订阅